HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Mechanisms of the hemodynamic effects of nonachlazine in ischemic heart disease patients].

Abstract
During course therapy with nonachlazine of patients with ischemic heart disease, stable angina pectoris a negative inotropic effect of the drug in persons with eukinetic and in particular hyperkinetic type of hemodynamics was revealed. Enhancement of beta-adrenoblocking effect of nonachlazine with an increase of its daily dose was found. Nonachlazine effect on hemodynamic parameters was shown to be mediated through adrenoreactive structures.
AuthorsR M Zaslavskaia, R D Zolotaia, I Kh Olevskiĭ, S G Duda, F A Vilkovyskiĭ
JournalFarmakologiia i toksikologiia (Farmakol Toksikol) 1986 Nov-Dec Vol. 49 Issue 6 Pg. 73-7 ISSN: 0014-8318 [Print] Russia (Federation)
Vernacular TitleK voprosu o mekhanizmakh gemodinamicheskikh éffektov nonakhlazina u bol'nykh ishemicheskoĭ bolezn'iu serdtsa.
PMID3817152 (Publication Type: English Abstract, Journal Article)
Chemical References
  • Phenothiazines
  • Nonachlazine
Topics
  • Adrenal Glands (drug effects)
  • Adult
  • Aged
  • Angina Pectoris (drug therapy, physiopathology)
  • Coronary Disease (drug therapy, physiopathology)
  • Drug Evaluation
  • Hemodynamics (drug effects)
  • Humans
  • Male
  • Middle Aged
  • Nonachlazine (pharmacology, therapeutic use)
  • Phenothiazines (pharmacology)
  • Physical Exertion (drug effects)
  • Sympathetic Nervous System (drug effects)
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: